X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13078) 13078
Publication (1087) 1087
Newspaper Article (150) 150
Book Review (103) 103
Newsletter (74) 74
Book Chapter (69) 69
Transcript (22) 22
Dissertation (20) 20
Conference Proceeding (15) 15
Book / eBook (9) 9
Magazine Article (4) 4
Data Set (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9620) 9620
index medicus (9113) 9113
oncology (4668) 4668
cancer (4112) 4112
cell line, tumor (4002) 4002
female (3719) 3719
animals (3709) 3709
male (3454) 3454
apoptosis (3174) 3174
expression (3131) 3131
metastasis (2735) 2735
lung cancer (2538) 2538
gene expression (2536) 2536
proteins (2525) 2525
middle aged (2459) 2459
mice (2370) 2370
tumors (2254) 2254
rna, small interfering - genetics (2249) 2249
cell biology (2202) 2202
cell proliferation (2159) 2159
lung cancer, non-small cell (2120) 2120
aged (1897) 1897
research (1853) 1853
rna interference (1786) 1786
prognosis (1781) 1781
gene expression regulation, neoplastic (1777) 1777
analysis (1621) 1621
signal transduction (1585) 1585
kinases (1550) 1550
health aspects (1545) 1545
genetic aspects (1517) 1517
biochemistry & molecular biology (1488) 1488
lung neoplasms - pathology (1483) 1483
rna, small interfering - metabolism (1482) 1482
care and treatment (1463) 1463
hepatocellular-carcinoma (1451) 1451
adult (1433) 1433
chemotherapy (1418) 1418
liver cancer (1385) 1385
proliferation (1379) 1379
development and progression (1371) 1371
medical prognosis (1335) 1335
cell cycle (1312) 1312
cell growth (1263) 1263
cancer therapies (1258) 1258
liver neoplasms - pathology (1248) 1248
growth (1237) 1237
carcinoma (1232) 1232
research article (1226) 1226
carcinoma, non-small-cell lung - pathology (1219) 1219
hepatocellular carcinoma (1217) 1217
lung neoplasms - genetics (1148) 1148
down-regulation (1141) 1141
medicine (1133) 1133
carcinoma, hepatocellular - pathology (1109) 1109
non-small cell lung cancer (1089) 1089
activation (1082) 1082
mice, nude (1054) 1054
micrornas - genetics (1033) 1033
non-small cell lung carcinoma (1033) 1033
immunohistochemistry (1028) 1028
multidisciplinary sciences (1023) 1023
studies (1018) 1018
rna (1017) 1017
lung neoplasms - metabolism (1003) 1003
medicine, research & experimental (999) 999
survival (999) 999
carcinoma, non-small-cell lung - genetics (998) 998
invasion (997) 997
genes (980) 980
liver (967) 967
transfection (955) 955
breast-cancer (943) 943
apoptosis - drug effects (909) 909
breast cancer (898) 898
phosphorylation (884) 884
blotting, western (854) 854
science (840) 840
article (833) 833
microrna (832) 832
small hepatocellular-carcinoma (832) 832
rna, small interfering (831) 831
cell proliferation - drug effects (826) 826
carcinoma, non-small-cell lung - metabolism (824) 824
micrornas (819) 819
sirna (813) 813
antineoplastic agents - pharmacology (812) 812
metastases (812) 812
inhibition (811) 811
surgery (798) 798
up-regulation (794) 794
biochemistry (778) 778
biology (769) 769
cell movement (767) 767
cells (766) 766
pharmacology & pharmacy (763) 763
gene knockdown techniques (760) 760
biomarkers (747) 747
liver neoplasms - metabolism (726) 726
liver neoplasms - genetics (721) 721
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13223) 13223
Japanese (90) 90
Chinese (88) 88
German (48) 48
French (30) 30
Korean (23) 23
Polish (4) 4
Spanish (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 10/2014, Volume 60, Issue 4, pp. 1302 - 1313
Hepatocellular carcinoma (HCC) has a poor prognosis as a result of widespread intra‐ and extrahepatic metastases. There is an urgent need to understand... 
WESTERN CENTER | OVEREXPRESSION | CHOLANGIOCARCINOMA | SIGNALING PATHWAYS | ACTIVATION | GENE | LIVER | GROWTH | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | ASPARTYL-(ASPARAGINYL)-BETA-HYDROXYLASE | Furans - pharmacology | Humans | Mixed Function Oxygenases - metabolism | Cell Movement - physiology | Receptors, Notch - antagonists & inhibitors | Carcinoma, Hepatocellular - drug therapy | Heterografts | Neoplasm Metastasis - drug therapy | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Membrane Proteins - metabolism | Biomarkers, Tumor - antagonists & inhibitors | Disease Models, Animal | Receptors, Notch - drug effects | Cell Proliferation - physiology | Enzyme Inhibitors - pharmacology | Liver Neoplasms - drug therapy | Mixed Function Oxygenases - antagonists & inhibitors | Sulfonic Acids - pharmacology | Cell Movement - drug effects | Animals | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | Mice, Nude | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Neoplasm Metastasis - physiopathology | Cell Line, Tumor | Membrane Proteins - drug effects | Cell Proliferation - drug effects | Mice | In Vitro Techniques | Mixed Function Oxygenases - drug effects | Carcinoma, Hepatocellular - metabolism | signaling pathway | HCC | ASPH | Notch | small molecule inhibitor
Journal Article
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 3, pp. 1012 - 1024.e4
Journal Article
Gastroenterology, ISSN 0016-5085, 10/2017, Volume 153, Issue 4, pp. 1107 - 1119.e10
Ligand binding to inhibitory receptors on immune cells, such as programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA4),... 
GPC3 | MAGEC2 | Immunotherapy | Galectin 9 | SAFETY | CANCER | RESPONSES | ADVANCED MELANOMA | PEPTIDE-MHC | NIVOLUMAB | GASTROENTEROLOGY & HEPATOLOGY | UP-REGULATION | PD-1 | TETRAMERS | EXHAUSTION | Tumor Escape - drug effects | Antigens, CD - immunology | Up-Regulation | Immunotherapy - methods | Coculture Techniques | Humans | Hepatitis A Virus Cellular Receptor 2 - metabolism | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antigens, CD - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors | Carcinoma, Hepatocellular - drug therapy | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Liver Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - metabolism | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - immunology | Hepatitis A Virus Cellular Receptor 2 - immunology | Cytokines - metabolism | Antibodies, Monoclonal - pharmacology | Cells, Cultured | Liver Neoplasms - drug therapy | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Neutralizing - pharmacology | Liver Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | CTLA-4 Antigen - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Carcinoma, Hepatocellular - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Viral antibodies | Cell death | Analysis | Melanoma | Antibodies | T cells | Lung cancer, Non-small cell | Cancer | Liver cancer | Dendritic cells | Tumor antigens | Lung cancer | Immunity
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 57, Issue 3, pp. 613 - 620
Journal Article
Small, ISSN 1613-6810, 01/2016, Volume 12, Issue 4, pp. 477 - 487
Journal Article